U.S. Oil and Gas Stock News

NYSE:DEC
NYSE:DECOil and Gas

A Look At Diversified Energy’s Valuation After Its Recent Share Price Rebound

Recent performance snapshot Diversified Energy (DEC) has attracted fresh attention after a strong recent share price move, with the stock showing double digit gains over the past week, month and past 3 months. See our latest analysis for Diversified Energy. The recent surge in DEC's share price, with a 39.05% 1 month share price return and 22.70% year to date share price return, sits against a 44.68% 1 year total shareholder return but weaker 3 and 5 year total shareholder returns. This...
NYSE:HIG
NYSE:HIGInsurance

Hartford’s Standout Earnings Beat And Revenue Growth Might Change The Case For Investing In HIG

Earlier this week, Hartford Insurance Group reported a very strong quarter, with revenue rising 6.7% year on year and results significantly ahead of analyst expectations compared with peers. What stands out is that Hartford delivered the biggest analyst estimate beat among its sector group, underscoring how its recent performance contrasts with many competitors. Now we’ll explore how this strong revenue growth and earnings beat may influence Hartford’s existing investment narrative and key...
NYSE:CB
NYSE:CBInsurance

Chubb Reshapes Overseas General Leadership For EMEA And APAC Growth

Chubb (NYSE:CB) has appointed Ben McGregor as Head of Commercial Property for EMEA and APAC within its Overseas General division. Alex Forman has been named Head of Commercial Casualty for EMEA and APAC, also within Overseas General. Both executives will oversee key international commercial insurance lines outside North America. For you as an investor, these moves sit at the heart of Chubb’s international commercial property and casualty franchise. EMEA and APAC are major hubs for corporate...
NYSE:GL
NYSE:GLInsurance

Globe Life (GL) Valuation Check After Recent Share Price Weakness And Reinsurance Cash Flow Plan

Globe Life stock in focus Globe Life (GL) is back on investors’ radar after recent share price moves, with the stock closing at US$135.11 and shorter term returns showing mixed performance over the past week and month. See our latest analysis for Globe Life. Recent share price returns have been soft, with a 6.27% 1 month share price decline and a 2.39% year to date share price decline. Longer term total shareholder returns of 4.97% over 1 year and 42.48% over 5 years point to steadier...
NasdaqGS:BHF
NasdaqGS:BHFInsurance

A Look At Brighthouse Financial (BHF) Valuation After Recent Share Price Weakness

Brighthouse Financial (BHF) is back on investors’ radar after a recent share move. The stock is trading around $59.98, with performance over the past month and past 3 months in focus. See our latest analysis for Brighthouse Financial. Recent price action has softened, with a 90 day share price return of a 7.51% decline and a year to date share price return of a 7.11% decline. However, the 1 year total shareholder return of 4.22% and 3 year total shareholder return of 35.98% indicate that...
NYSE:EL
NYSE:ELPersonal Products

Estée Lauder Weighs Puig Tie Up And India Push In Turnaround

Estée Lauder Companies (NYSE:EL) has confirmed discussions about a potential business combination with Puig that could create one of the largest listed beauty firms globally. The company has also agreed to acquire the remaining interests in Indian luxury beauty brand Forest Essentials, moving toward full ownership. These developments arrive while Estée Lauder works through ongoing turnaround efforts and reassesses its global footprint. For shareholders watching NYSE:EL at a current share...
NasdaqGS:ITRI
NasdaqGS:ITRIElectronic

Can Itron (ITRI) Turn New AI Grid Partnerships Into a Durable Software-Led Moat?

In March 2026, Itron, Inc. expanded its grid solutions footprint by supporting Ausgrid’s rollout of the IntelliFLEX LV DERMS platform in Australia and deepening its AI-powered distributed intelligence collaboration with NVIDIA for real-time grid-edge monitoring and anomaly detection. Together, these moves highlight Itron’s push toward higher-value software, analytics, and grid management capabilities that address increasingly complex reliability and safety needs for utilities. We’ll now...
NasdaqGS:ASML
NasdaqGS:ASMLSemiconductor

Is It Too Late To Consider ASML Holding (NasdaqGS:ASML) After 94% One-Year Surge?

Wondering if ASML Holding at around US$1,302 a share still offers value or if the easy gains are behind it? This article walks through the numbers so you can judge that for yourself. The stock has returned 11.9% year to date, 94.5% over the last year, and 112.7% over five years, but it has also seen a 1.1% pullback over the last week and a 14.7% decline over the last month. These recent moves come against a backdrop of ongoing attention on ASML Holding as a key supplier to the semiconductor...
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

TransMedics Group (TMDX) Is Down 13.0% After ENHANCE Heart IDE Approval And Platform Expansion - Has The Bull Case Changed?

Earlier in 2026, TransMedics Group reported US$727–US$757 million in 2026 revenue guidance, a higher operating margin of 13% in the latest quarter, and secured full FDA IDE approval for its ENHANCE Heart trial as it expands its National OCS Program to nearly 30% of U.S. transplant procedures. Beyond device sales, TransMedics is moving toward a vertically integrated transplant platform that could become embedded in the federal transplant ecosystem by 2027, potentially reshaping how multiple...
NYSE:EG
NYSE:EGInsurance

Everest Group Canada Sale And Rating Review Create Valuation Questions

Everest Group (NYSE:EG) has agreed to sell 100% of Everest Insurance Company of Canada to The Wawanesa Mutual Insurance Company. Following the announcement, AM Best placed Everest Canada’s financial strength and credit ratings under review with negative implications. The proposed transaction is subject to regulatory approvals and closing conditions, adding timing and execution uncertainty for investors and policyholders. Everest Group is a global reinsurance and insurance provider, and its...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna Faces EMA Approval And FDA Pushback As Valuation Risks Mount

Moderna (NasdaqGS:MRNA) has received European Medicines Agency approval for its mRNA flu vaccine, following efficacy data in older adults. In the U.S., the FDA initially declined to review the same vaccine application, despite positive clinical results cited by the company. Moderna’s CEO has warned that the company may scale back late-stage development in the U.S., pointing to concerns about regulatory and political pressures. The split between EU and U.S. regulators is raising questions...
NasdaqCM:VRRM
NasdaqCM:VRRMProfessional Services

Verra Mobility’s Sales Growth Meets Profitability Strains And Cooling Sentiment

Verra Mobility, NasdaqCM:VRRM, is reporting long term sales growth alongside pressure on free cash flow margins. Recent quarterly results show weaker profitability, prompting questions about investment needs and cost control. Investor sentiment has cooled, with the share price at $13.88 and a 37.8% decline year to date. For shareholders, the story around Verra Mobility is no longer just about sales momentum. The stock is down 37.8% year to date and 31.3% over the past year, with the current...
NasdaqGS:SFD
NasdaqGS:SFDFood

Smithfield Foods (SFD) Is Up 15.4% After Record Profit And Nathan’s Famous Deal - What's Changed

In March 2026, Smithfield Foods reported higher fourth-quarter and full-year 2025 results, issued 2026 guidance for low-single-digit sales growth, announced a quarterly dividend of US$0.3125 per share, and outlined an agreement to acquire the Nathan's Famous packaged meats brand while continuing to evaluate additional M&A opportunities. A key takeaway for investors is Smithfield Foods’ record 2025 operating profit of US$1.30 billion and margin expansion to 8.6%, highlighting improved...
NYSE:HSY
NYSE:HSYFood

Is Hershey (HSY) Still Attractive After A 29.7% One Year Share Price Gain?

If you are wondering whether Hershey at around US$213.73 is still a fair deal or already pricing in a lot of optimism, you are asking the right question that this valuation focused piece will tackle. Over the past year the stock has returned 29.7%, with a 17.2% gain year to date, even as the last month shows a 6.9% decline and the last three years sit at a 8.7% loss. Recent coverage has highlighted Hershey's ongoing position as a major packaged foods name, and investors have been weighing...
NYSE:WSM
NYSE:WSMSpecialty Retail

Williams-Sonoma Expansion And Hill House Deal Test Market Undervaluation

Williams-Sonoma (NYSE:WSM) is launching its first major retail expansion in more than ten years, adding new and refreshed stores across key locations. The company is also rolling out a high-profile collaboration with lifestyle brand Hill House Home for its Pottery Barn Kids and Pottery Barn Teen banners. The expansion and partnership are positioned alongside Williams-Sonoma's existing digital and direct-to-consumer strengths. Williams-Sonoma, known for its home, kitchen, and specialty...
NasdaqGS:SPRO
NasdaqGS:SPROBiotechs

Spero Therapeutics (SPRO) Earnings Turn Positive Challenging Bearish Profitability Narratives

Spero Therapeutics (SPRO) closed FY 2025 with fourth quarter revenue of US$41.3 million and basic EPS of US$0.56, alongside trailing twelve month revenue of US$66.8 million and EPS of roughly US$0.15 that mark a shift into profitability over the period. Over recent quarters, the company has seen revenue range from US$5.4 million to US$41.3 million with quarterly EPS moving from a loss of about US$0.25 per share at the start of FY 2025 to a profit in the latest quarter, providing a clearer...
NYSE:BTGO
NYSE:BTGOCapital Markets

Bitgo Holdings (BTGO) Revenue Surge Tests Thin 0.5% Margin Narrative

Bitgo Holdings FY 2025 Earnings Snapshot Bitgo Holdings (BTGO) just posted its FY 2025 results with third quarter revenue of about US$5.8 billion, Basic EPS of US$0.19 and net income of US$6.8 million. Trailing twelve month revenue stood at roughly US$11.1 billion with Basic EPS of US$1.49 and net income of US$57.1 million. The company has seen quarterly revenue move from US$817.8 million in FY 2024 Q3 to US$5.8 billion in FY 2025 Q3, and Basic EPS shift from US$0.11 in FY 2024 Q1 and Q2 to...
NasdaqGS:GILT
NasdaqGS:GILTCommunications

A Look At Gilat Satellite Networks (GILT) Valuation After New Defense Orders And SATELLITE 2026 Cloud Demo News

Gilat Satellite Networks (GILT) is back in focus after announcing a joint SATELLITE 2026 demonstration with Amazon Web Services and partners, along with fresh U.S. Army service orders through its Gilat DataPath unit. See our latest analysis for Gilat Satellite Networks. The latest U.S. Army orders and the upcoming SATELLITE 2026 cloud modem demo arrive after a 1 year total shareholder return of 137.5% and a 3 year total shareholder return of roughly 3x. At the same time, the recent 7 day...
NasdaqGS:STRS
NasdaqGS:STRSReal Estate

Stratus Properties (STRS) Q3 Loss Deepens And Reinforces Bearish Profitability Narrative

Stratus Properties (STRS) has just posted another tough quarter, with Q3 FY 2025 revenue of US$5.0 million and a basic EPS loss of US$0.62, alongside a net income loss of US$5.0 million. The trailing twelve month picture shows total revenue of US$31.9 million and a net income loss of US$8.1 million. Over recent periods the company has seen quarterly revenue move between US$4.9 million and US$11.6 million, with basic EPS ranging from a small profit of US$0.03 per share to losses of up to...
NYSE:TDW
NYSE:TDWEnergy Services

Is Tidewater (TDW) Pricing Reflect Its Surge After Recent Energy Services Sector Focus

If you are wondering whether Tidewater's current share price really reflects its underlying worth, you are not alone. The stock last closed at US$82.40, with returns of 13.7% over 7 days, 4.9% over 30 days, 57.8% year to date, and 89.6% over 1 year that many investors will be paying close attention to. Recent news coverage has focused on Tidewater's role within the energy services space and how investors are reacting to sector wide sentiment. This context helps frame why the recent price...
NasdaqCM:CV
NasdaqCM:CVMedical Equipment

CapsoVision (CV) Q4 Loss Of US$0.16 EPS Tests Bullish Profitability Narratives

CapsoVision (CV) closed FY 2025 with fourth quarter revenue of US$3.9 million, a basic EPS loss of US$0.16 per share, and trailing twelve month revenue of US$13.6 million alongside a trailing EPS loss of US$1.03 per share. Over recent quarters, revenue has moved from US$3.5 million in Q3 2025 and US$3.3 million in Q2 2025 to the latest US$3.9 million print. Basic EPS losses shifted from US$0.17 and US$2.02 over those same periods to US$0.16, leaving investors focused on how quickly margins...
NYSE:CCL
NYSE:CCLHospitality

Carnival Corporation (CCL) 10.4% Net Margin Strengthens Bullish Earnings Narrative

Carnival Corporation (CCL) has kicked off Q1 2026 following a solid run through 2025, with Q4 2025 revenue of US$6.3 billion, basic EPS of US$0.32 and net income of US$422 million framing the latest set of numbers. Over the past few quarters, revenue has moved from US$5.9 billion in Q4 2024 to US$6.3 billion in Q2 2025 and again US$6.3 billion in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.06 in Q1 2025 to US$1.41 in Q3 2025. This has set up a story where rising trailing...
NasdaqGS:PRVA
NasdaqGS:PRVAHealthcare

A Look At Privia Health Group (PRVA) Valuation After Recent Share Price Pressure

Privia Health Group (PRVA) has been drawing attention after recent share price pressure, with the stock showing negative returns over the past month and past 3 months as investors reassess expectations. See our latest analysis for Privia Health Group. With the latest share price at $20.02, the stock’s 30 day share price return of 11.61% and year to date share price return of a 14.66% decline sit alongside a 3 year total shareholder return of a 27.49% decline, pointing to fading momentum as...
NYSE:SOLV
NYSE:SOLVMedical Equipment

Is Solventum (SOLV) Offering Value After Recent 16% Monthly Share Price Slide

If you are wondering whether Solventum's current share price still reflects its underlying worth, you are not alone. Many investors are asking the same question as they reassess what counts as good value in healthcare. Over the past month, Solventum's share price moved from recent levels to close at US$62.76, with a 7 day return of a 4.6% decline and a 30 day return of a 16.4% decline that adds to a 20.6% decline year to date and a 16.0% decline over the last year. These moves have come as...